These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 21871156

  • 1. (±)-3,4-methylenedioxymethamphetamine and metabolite disposition in plasma and striatum of wild-type and multidrug resistance protein 1a knock-out mice.
    Scheidweiler KB, Ladenheim B, Barnes AJ, Cadet JL, Huestis MA.
    J Anal Toxicol; 2011 Sep; 35(7):470-80. PubMed ID: 21871156
    [Abstract] [Full Text] [Related]

  • 2. Mice lacking multidrug resistance protein 1a show altered dopaminergic responses to methylenedioxymethamphetamine (MDMA) in striatum.
    Scheidweiler KB, Ladenheim B, Cadet JL, Huestis MA.
    Neurotox Res; 2010 Aug; 18(2):200-9. PubMed ID: 19851718
    [Abstract] [Full Text] [Related]

  • 3. Plasma pharmacokinetics of 3,4-methylenedioxymethamphetamine after controlled oral administration to young adults.
    Kolbrich EA, Goodwin RS, Gorelick DA, Hayes RJ, Stein EA, Huestis MA.
    Ther Drug Monit; 2008 Jun; 30(3):320-32. PubMed ID: 18520604
    [Abstract] [Full Text] [Related]

  • 4. 3,4-Methylenedioxymethamphetamine (MDMA) and metabolites disposition in blood and plasma following controlled oral administration.
    Hartman RL, Desrosiers NA, Barnes AJ, Yun K, Scheidweiler KB, Kolbrich-Spargo EA, Gorelick DA, Goodwin RS, Huestis MA.
    Anal Bioanal Chem; 2014 Jan; 406(2):587-99. PubMed ID: 24232751
    [Abstract] [Full Text] [Related]

  • 5. Analysis of MDMA and its metabolites in urine and plasma following a neurotoxic dose of MDMA.
    Valtier S, Phelix CF, Cody JT.
    J Anal Toxicol; 2007 Apr; 31(3):138-43. PubMed ID: 17579960
    [Abstract] [Full Text] [Related]

  • 6. Studies of (±)-3,4-methylenedioxymethamphetamine (MDMA) metabolism and disposition in rats and mice: relationship to neuroprotection and neurotoxicity profile.
    Mueller M, Maldonado-Adrian C, Yuan J, McCann UD, Ricaurte GA.
    J Pharmacol Exp Ther; 2013 Feb; 344(2):479-88. PubMed ID: 23209329
    [Abstract] [Full Text] [Related]

  • 7. Nonlinear pharmacokinetics of (+/-)3,4-methylenedioxymethamphetamine (MDMA) and its pharmacodynamic consequences in the rat.
    Concheiro M, Baumann MH, Scheidweiler KB, Rothman RB, Marrone GF, Huestis MA.
    Drug Metab Dispos; 2014 Jan; 42(1):119-25. PubMed ID: 24141857
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Further studies on the role of metabolites in (+/-)-3,4-methylenedioxymethamphetamine-induced serotonergic neurotoxicity.
    Mueller M, Yuan J, Felim A, Neudörffer A, Peters FT, Maurer HH, McCann UD, Largeron M, Ricaurte GA.
    Drug Metab Dispos; 2009 Oct; 37(10):2079-86. PubMed ID: 19628751
    [Abstract] [Full Text] [Related]

  • 10. Contribution of cytochrome P450 2D6 to 3,4-methylenedioxymethamphetamine disposition in humans: use of paroxetine as a metabolic inhibitor probe.
    Segura M, Farré M, Pichini S, Peiró AM, Roset PN, Ramírez A, Ortuño J, Pacifici R, Zuccaro P, Segura J, de la Torre R.
    Clin Pharmacokinet; 2005 Oct; 44(6):649-60. PubMed ID: 15910012
    [Abstract] [Full Text] [Related]

  • 11. Urinary MDMA, MDA, HMMA, and HMA excretion following controlled MDMA administration to humans.
    Abraham TT, Barnes AJ, Lowe RH, Kolbrich Spargo EA, Milman G, Pirnay SO, Gorelick DA, Goodwin RS, Huestis MA.
    J Anal Toxicol; 2009 Oct; 33(8):439-46. PubMed ID: 19874650
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Sprague-Dawley rats display sex-linked differences in the pharmacokinetics of 3,4-methylenedioxymethamphetamine (MDMA) and its metabolite 3,4-methylenedioxyamphetamine (MDA).
    Fonsart J, Menet MC, Debray M, Hirt D, Noble F, Scherrmann JM, Declèves X.
    Toxicol Appl Pharmacol; 2009 Dec 15; 241(3):339-47. PubMed ID: 19781562
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Stereoselective urinary MDMA (ecstasy) and metabolites excretion kinetics following controlled MDMA administration to humans.
    Schwaninger AE, Meyer MR, Barnes AJ, Kolbrich-Spargo EA, Gorelick DA, Goodwin RS, Huestis MA, Maurer HH.
    Biochem Pharmacol; 2012 Jan 01; 83(1):131-8. PubMed ID: 21983032
    [Abstract] [Full Text] [Related]

  • 16. Hair analysis for drug abuse. XV. Disposition of 3, 4-methylenedioxymethamphetamine (MDMA) and its related compounds into rat hair and application to hair analysis for MDMA abuse.
    Kikura R, Nakahara Y, Mieczkowski T, Tagliaro F.
    Forensic Sci Int; 1997 Jan 17; 84(1-3):165-77. PubMed ID: 9042722
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Determination of MDMA and its metabolites in blood and urine by gas chromatography-mass spectrometry and analysis of enantiomers by capillary electrophoresis.
    Pizarro N, Ortuño J, Farré M, Hernández-López C, Pujadas M, Llebaria A, Joglar J, Roset PN, Mas M, Segura J, Camí J, de la Torre R.
    J Anal Toxicol; 2002 Apr 17; 26(3):157-65. PubMed ID: 11991532
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.